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Objective: Anxiety and depression are highly prevalent in patients with COPD and their 
informal carers, and associated with numerous risk factors. However, few studies have inves-
tigated these in primary care or the link between patient and carer anxiety and depression. 
We aimed to determine this association and factors associated with anxiety and depression in 
patients, carers, and both (dyads), in a population-based sample.
Materials and methods: This was a prospective, cross-sectional study of 119 advanced COPD 
patients and their carers. Patient and carer scores $8 on the Hospital Anxiety and Depression 
Scale defined symptoms of anxiety and depression, χ2 tests determined associations between 
patient and carer symptoms of anxiety/depression, and χ2 and independent t-tests for normally 
distributed variables (otherwise Mann–Whitney U tests) were used to identify other variables 
significantly associated with these symptoms in the patient or carer. Patient–carer dyads were 
categorized into four groups relating to the presence of anxious/depressive symptoms in: both 
patient and carer, patient only, carer only, and neither. Factors associated with dyad symptoms of 
anxiety/depression were determined with χ2 tests and one-way analysis of variance for normally 
distributed variables (otherwise Kruskal–Wallis tests).
Results: Prevalence of symptoms of anxiety and depression was 46.4% (n=52) and 42.9% (n=48) 
in patients, and 46% (n=52) and 23% (n=26) in carers, respectively. Patient and carer symptoms 
of anxiety/depression were significantly associated. Anxious and depressive symptoms in the 
patient were also significantly associated with more physical comorbidities, more exacerba-
tions, greater dyspnea, greater fatigue, poor mastery, and depressive symptoms with younger 
age. Symptoms of carer anxiety were significantly associated with being female and separated/
divorced/widowed, and depressive symptoms with younger age, higher educational level, and 
more physical comorbidities, and symptoms of carer anxiety and depression with more unmet 
support needs, greater subjective caring burden, and poor patient mastery. Dyad symptoms of 
anxiety/depression were significantly associated with greater patient fatigue.
Conclusion: Symptoms of anxiety and depression in COPD patients and carers are significantly 
associated. Given their high prevalence, considerable impact on mortality, impact on quality of 
life and health care use, and associations with each other, screening for and addressing patient 
and carer anxiety and depression in advanced COPD is recommended.
Keywords: COPD, anxiety, depression, informal carers, patient–carer dyad
Plain language summary
Anxiety and depression are very common in patients with COPD and family or friends who 
provide care and support (carers). We wanted to find out whether these psychological health 
problems in patients and carers were linked and what the risk factors are for patients, carers, or 
both being anxious or depressed. Knowing these might help us target patients and carers most 
at risk and improve the management of psychological health in COPD. We collected informa-
tion from 119 patients with advanced COPD and their carers. Up to 40% of these patients and 
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carers had symptoms of anxiety and/or depression. Anxious and 
depressed patients were more likely to have anxious and depressed 
carers. Symptoms of anxiety and depression were more common in 
patients who were more symptomatic and those with poor control of 
their lung problem and other physical health problems. Symptoms 
of depression alone were found more in patients who were younger. 
More anxious carers were female and separated and divorced or 
widowed, and more depressed carers were younger, more highly 
educated, and had physical health problems themselves. Carers 
who were either more anxious or depressed had more unmet sup-
port needs, felt they had a higher caring burden, and had patients 
with less control of their lung problem. Symptoms of anxiety or 
depression in both a patient and their carer were linked to patient 
fatigue. Our results suggest that it is important to screen for and 
address anxiety and depression not only in patients with COPD but 
also carers, especially of patients with anxiety or depression.
Introduction
Anxiety and depression are common in COPD, with reported 
prevalence ranges of 10%–55% and 7%–42%, respectively.1–3 
They decrease treatment adherence and are associated with 
higher mortality,2–4 poorer health-related quality of life,1–8 
and increased hospital admissions.2,3,9 Previous studies have 
identified numerous risk factors for anxiety and depression 
in patients, including younger age,4,7,8,10 being female,4,5,8,10 
living alone,6 current smoking,2–4,8,10 and comorbidities.3,4 
Poor psychological health preferentially coexists with fre-
quent exacerbations,4,8,9 dyspnoea,4,5,8,10–12 fatigue,4 impaired 
physical functioning and reduced exercise capacity,2–4,6,8,10 
and low self-efficacy.2,9
As COPD progresses and becomes advanced, patients 
become increasingly dependent on informal carers (family 
members or friends). Anxiety and depression are known 
to be as prevalent in carers as in patients, with up to 63% 
reporting clinically significant anxiety symptoms and 51% 
reporting depressive symptoms.13,14 Older age,13,15,16 being 
female,13,15,17,18 and spousal patient–carer relationship13,14 
have been associated with carer psychological morbidities. 
Low educational level,13,16 lack of support,19,20 and poor carer 
health18 are also risk factors, as are disease factors such as 
severity,13–15 exacerbations,20 and dyspnea.13,14 Subjective 
carer burden (carer’s appraisal of the impact of the role on 
their health, social and occupational life, finances, and reac-
tions to caring)13–15,18,21 has been significantly associated with 
anxiety and depression, but the evidence for objective carer 
burden (such as time spent caregiving) is mixed.13,14,21
However, the majority of studies have investigated 
psychological health in secondary-care cohorts (eg, patients 
admitted to hospital for exacerbations), which does not rep-
resent the whole population of people living with advanced 
COPD.14,18,19 Few studies have been conducted in the primary-
care setting.7 Also, while they have been studied separately, 
less is known about the association between patient and 
carer anxiety and depression, and factors associated with 
both patient and carer anxiety and depression in the dyad are 
unknown. We aimed to determine the association between 
patient and carer anxiety and depression and factors associ-
ated with anxiety and depression in patients, carers, and 
both in the dyad in a population-based cohort, sampled from 
primary care.
Materials and methods
study design and participants
This cross-sectional study was an analysis of data from 
patients and carers who participated in baseline interviews 
for the longitudinal interview-study component of the larger 
prospective Living with Breathlessness study.22 In the longi-
tudinal interview study, 652 patients with advanced COPD 
were identified by 63 primary-care practices in the east of 
England and mailed a recruitment pack: 248 patients agreed 
to participate, of whom 235 consented and participated (36% 
participation rate). Targeting of practice types maximized 
their variability to achieve representativeness. Patients with 
well-characterized advanced COPD were recruited, who 
met at least two of six inclusion criteria: forced expiratory 
volume in 1 second (FEV
1
) ,30%, two or more exacerba-
tions requiring prednisolone or antibiotics in the previous 
year, one or more hospital admission for COPD in the 
previous 2 years, long-term oxygen therapy, cor pulmonale 
and Medical Research Council dyspnea scale score $4. 
Exclusion criteria were serious mental health problem, seri-
ous learning difficulty, active cancer, and active alcoholism. 
Patients were asked to identify their primary informal carer, 
who was also invited to participate. Carer-exclusion criteria 
were under 18 years of age and unable to give informed 
consent; 119 carers consented and effectively participated 
(51% participation rate). The study received ethics approval 
from the National Research Ethics Service Committee East of 
England – Cambridge South (12/EE/0163). All participants 
gave written informed consent.
Data collection
Data were collected during face-to-face interviews with 
patients and carers in their home setting. Interviews with 
patients and carers were conducted separately wherever 
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possible; occasionally, the physical layout of the home made 
separate interviews impossible. Sociodemographics and 
clinical characteristics of participants were obtained. Data on 
the caring situation (patient–carer kin relationship, cohabi-
tation, duration of caring, and hours of caring per week) 
were also collected. Patients completed the 20-item Chronic 
Respiratory Questionnaire (CRQ; self-administered standard-
ized version)23 to measure disease-specific health-related 
quality of life: items scored on a 7-point scale contribute 
to four subdomains of dyspnea, fatigue, emotional func-
tion, and mastery (how in control the patient feels of their 
condition), each scored 0–7, with higher scores indicating 
better health-related quality of life. Carers rated subjective 
caring burden on the Family Appraisal of Caregiving 
Questionnaire – palliative care, addressing caregiver strain 
(feelings of fatigue, isolation, lack of control, negative impact 
on own health, social life, occupational life, and finances), 
caregiver distress (anxiety and depression), and positive 
caregiving appraisals (commitment, satisfaction, stronger 
relationship), with each statement scored on a 5-point Likert 
scale ranging from strong agreement to strong disagreement.24 
Carers identified unmet support needs with the Carer Support 
Needs Assessment Tool, which covers 14 support domains 
in two groupings of support to enable the carer to provide 
care for the patient (eg, managing symptoms, including 
giving medicines) and direct support for carers’ own health 
and well-being (eg, dealing with feelings and worries), with 
the need for more support indicated on a 4-point categorical 
scale from 0 (none) to 3 (very much more).25 Patient and carer 
psychological health was assessed with the 14-item Hospital 
Anxiety and Depression Scale (HADS), a well-validated and 
reliable self-report screening tool for symptoms of anxiety 
and depression, which is analyzed as two separate 7-item 
subscales for anxiety (HADS-A) and depression (HADS-D), 
each with a total score of 0–21.26 Of the 119 patients who 
had a participating carer, 112 patients completed the HADS 
questionnaire; of the 119 carers, 113 carers provided 
responses to the questionnaire. Symptoms of anxiety and 
depression were defined as HADS-A and HADS-D score $8, 
the commonly used threshold for mild symptoms of anxiety 
and depression.27
statistical analysis
To determine associations between patient and carer symp-
toms of anxiety and depression, χ2 tests were used; χ2 and 
independent t-tests for normally distributed variables (oth-
erwise Mann–Whitney U tests) were used to identify other 
variables significantly associated with anxious or depressive 
symptoms in the patient or carer. Dyads were then catego-
rized into four groups relating to the presence of anxious or 
depressive symptoms: both patient and carer, patient only, 
carer only, and neither. Factors significantly associated with 
symptoms of anxiety or depression in both (dyad symptoms 
of anxiety or depression) were determined with χ2 tests and 
one-way analysis of variance (with Bonferroni post hoc tests) 
for normally distributed variables (otherwise Kruskal–Wallis 
tests). Statistical significance was set at P#0.05. All statis-
tical analyses were performed in SPSS version 23 (IBM, 
Armonk, NY, USA).
Results
The mean age (±SD) of patients and carers was 71.4±8.7 years 
and 64.2±14.5 years; 39.3% of patients and 72.6% of carers 
were female. The prevalence of symptoms of anxiety and 
depression was 46.4% (n=52) and 42.9% (n=48) in patients, 
and 46% (n=52) and 23% (n=26) in carers, respectively. 
Symptoms of patient anxiety were significantly associ-
ated with carer anxiety (χ2=6.475, P=0.011) and depres-
sion (χ2=3.86, P=0.049). Symptoms of patient depression 
were also significantly associated with both carer anxiety 
(χ2=6.249, P=0.012) and depression (χ2=11.032, P=0.011). 
Additional factors associated with patient and carer anxious 
and depressive symptoms are shown in Tables 1 and 2.
Symptoms of patient depression were significantly 
associated with younger age, and symptoms of anxiety and 
depression with each other, more patient physical comorbidi-
ties, more exacerbations at home, greater dyspnea, greater 
fatigue, and poor mastery. Symptoms of carer anxiety 
were associated with being female and separated/divorced/
widowed, symptoms of depression with younger age, higher 
educational level, and more carer physical comorbidities, and 
symptoms of anxiety and depression with each other, more 
unmet support needs, greater subjective caring burden, and 
poor patient mastery.
The number of dyads in which both patient and carer had 
symptoms of anxiety or depression was 37, in which only the 
patient had these symptoms 28, in which only the carer had these 
symptoms 15, and in which neither had these symptoms 29. 
Dyad symptoms of anxiety or depression were significantly 
associated with lower mean patient CRQ fatigue score (repre-
senting higher fatigue) compared to dyads in which only the 
patient (2.5 vs 3, P=0.049), the carer (2.5 vs 4.2, P,0.0005), 
or neither (2.5 vs 4, P,0.0005) had symptoms of anxiety or 
depression (Figure 1).
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Discussion
To our knowledge, this is the first study to show that symp-
toms of anxiety and depression in patients and carers living 
with advanced COPD are significantly associated with each 
other in a population-based sample. One mechanism for this 
may be emotional contagion, where individuals in close rela-
tionships mimic each other’s emotions (seen in facial expres-
sions), with stronger associations in more severe distress.28
It is possible to interpret these findings within Rolland’s 
family-systems illness model to help our understanding.29–32 
The relapsing unpredictable disease course of COPD may 
be particularly taxing for families to adjust to, resulting in 
substantial psychological incongruity between periods of 
chronic disease and relapse, and anticipatory anxiety. There is 
also the risk of families coming together to deal with exacer-
bations and hospital admissions, but remaining “enmeshed”, 
which may be maladaptive in the chronic phase of COPD, 
leading to family burnout and permanent distortion of the 
patient–family relationship. As the patients in our study had 
advanced COPD, families may also have been living in the 
terminal phase, with issues of loss and need for family reor-
ganization. Taken together, these factors may contribute to 
the high prevalence of symptoms of anxiety and depression 
in both the patient and carer cohorts.
Table 1 Factors associated with symptoms of patient anxiety and depression
Factors Patients with 
symptoms of 
anxiety (n=52)
Patients without 
symptoms of 
anxiety (n=60)
P-value Patients with 
symptoms of 
depression (n=48)
Patients without 
symptoms of 
depression (n=64)
P-value
age, years 70 (65–74) 73 (66–78.8) 0.135 66 (62–73) 74.5 (69.3–80) ,0.0005*
sex (female), n (%) 20 (38.5) 24 (40) 0.868 18 (37.5) 26 (40.6) 0.738
Marital status, n (%)
single 1 (1.9) 0 0.581 0 1 (1.6) 1
With partner 45 (86.5) 50 (84.7) 41 (85.4) 54 (85.7)
separated/divorced/widowed 6 (11.5) 9 (15.3) 7 (14.6) 8 (12.7)
living alone, n (%) 5 (9.6) 6 (10) 0.946 5 (10.4) 6 (9.4) 1
educational level, n (%)
none 27 (67.5) 25 (52.1) 0.084 24 (66.7) 28 (53.8) 0.485
a level/O level 9 (22.5) 9 (18.8) 6 (16.7) 12 (23.1)
higher 4 (10) 14 (29.2) 6 (16.7) 12 (23.1)
Income, n (%)
,£220/week 10 (20) 9 (16.7) 0.903 11 (25) 8 (13.3) 0.3
£221–£350/week 20 (40) 22 (40.7) 17 (38.6) 25 (41.7)
.£350/week 20 (40) 23 (42.6) 16 (36.4) 27 (45)
Patient–carer spousal relationship, n (%) 39 (76.5) 50 (84.7) 0.271 36 (76.6) 53 (84.1) 0.32
Patient–carer cohabitation, n (%) 44 (84.6) 54 (90) 0.39 41 (85.4) 57 (89.1) 0.564
smoking status, n (%)
Current smoker 9 (17.3) 9 (15) 0.92 11 (22.9) 7 (10.9) 0.22
Former smoker 42 (80.8) 49 (81.7) 36 (75) 55 (85.9)
never smoked 1 (1.9) 2 (3.3) 1 (2.1) 2 (3.1)
Duration of COPD 10 (6.3–15) 8 (5–13) 0.129 7 (4–13) 6.5 (3–12) 0.366
Disease-severity measures
% predicted FeV1, mean (sD) 43.7 (22.3) 34.9 (19.2) 0.154 37.8 (26.5) 38.3 (17.2) 0.941
mMrC dyspnea scale 4 (3–5) 4 (3–4) 0.507 4 (3–5) 4 (3–4) 0.226
exacerbations requiring admission, n 0 (0–1) 0 (0–1) 0.652 0 (0–1) 0 (0–1) 0.972
exacerbations at home, n 3 (2–5.5) 2 (0–3) 0.001* 3 (2–6) 2 (0–3) 0.011*
CrQ domains
Dyspnea 1.8 (1.4–2.8) 2.8 (2.2–4) ,0.0005* 1.8 (1.4–2.6) 3 (2.2–4) ,0.0005*
Fatigue 2.5 (2–3) 4.3 (3.1–4.9) ,0.0005* 2.5 (2–3) 3.8 (3–4.9) ,0.0005*
Mastery, mean (sD) 3.4 (1) 5.1 (1) ,0.0005* 3.6 (1.2) 4.8 (1.2) ,0.0005*
Patient comorbidities
Physical comorbidities,a n 4 (3–6) 3 (2–4) 0.002* 4 (3–6) 3.5 (2–4) 0.002*
anxiety symptoms, n (%) na na na 34 (70.8) 18 (28.1) ,0.0005*
Depression symptoms, n (%) 24 (65.4) 14 (23.3) ,0.0005* na na na
Notes: aany of allergies, arthritis, asthma, back pain, cancer, diabetes, epilepsy, cardiac disease, hypertension, renal disease, hepatic disease, or stroke. all values medians 
(IQr) unless otherwise stated. *P#0.05.
Abbreviations: FeV1, forced expiratory volume in 1 second; mMRC, modified Medical Research Council; CRQ, Chronic Respiratory Questionnaire; NA, not applicable.
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Patient depression was significantly associated with 
younger age, possibly due to greater difficulty adjusting to dis-
ease limitations.7,10 The link between exacerbations, dyspnea 
and anxiety may be explained by the dyspnea–anxiety–dyspnea 
cycle11 and cognitive model of panic,12 a catastrophic misin-
terpretation of the sensation of dyspnea, possibly due to 
chemoreceptor hypersensitivity to CO
2
 or processing of 
the affective dimension of dyspnea and anxiety in common 
Table 2 Factors associated with symptoms of carer anxiety and depression
Carers with 
symptoms of 
anxiety (n=52)
Carers without 
symptoms of 
anxiety (n=61)
P-value Carers with 
symptoms of 
depression (n=26)
Carers without 
symptoms of 
depression (n=87)
P-value
age, years 63 (53–71) 68.5 (60.3–77) 0.079 60 (51–69.3) 69 (60–76) 0.017*
sex (female), n (%) 44 (84.6) 38 (62.3) 0.008* 20 (76.9) 62 (71.3) 0.57
Marital status, n (%)
single 3 (5.9) 4 (6.7) 0.023* 1 (3.8) 6 (7.1) 0.635
With partner 40 (78.4) 55 (91.7) 22 (84.6) 73 (85.9)
separated/divorced/widowed 8 (15.7) 1 (1.7) 3 (11.5) 6 (7.1)
living alone, n (%) 1 (1.9) 1 (1.6) 1 0 (0) 2 (2.3) 1
educational level, n (%)
none 28 (66.7) 23 (52.3) 0.131 12 (60) 39 (59.1) 0.044*
a/O level 5 (11.9) 13 (29.5) 1 (5) 17 (25.8)
higher 9 (21.4) 9 (18.2) 7 (35) 10 (15.2)
Income, n (%)
,£220/week 12 (26.1) 5 (9.8) 0.109 5 (21.7) 12 (16.2) 0.797
£221–£350/week 16 (34.8) 22 (43.1) 8 (34.8) 30 (40.5)
.£350/week 18 (39.1) 24 (47.1) 10 (43.5) 32 (43.2)
Patient–carer spousal relationship, n (%) 40 (76.9) 51 (83.6) 0.371 21 (80.8) 70 (80.5) 1
Patient–carer cohabitation, n (%) 43 (84.3) 55 (93.2) 0.135 22 (84.6) 76 (90.5) 0.473
Duration of caring 6 (2.5–12) 7 (3–13) 0.395 9.5 (3–13.5) 7 (3–12) 0.728
hours of caring/week, n (%)
,19 18 (37.5) 23 (41.8) 0.687 9 (36) 32 (41) 0.143
20–49 15 (31.3) 13 (23.6) 4 (16) 24 (30.8)
.50 15 (31.3) 19 (34.5) 12 (48) 22 (28.2)
Patient disease-severity measures
% predicted FeV1, mean (sD) 39.1 (22.2) 37.5 (19.1) 0.774 41.8 (25.2) 40 (18.7) 0.463
mMrC dyspnea scale 4 (3–4.3) 4 (3–5) 0.602 4 (3–5) 4 (3–4) 0.143
exacerbations requiring admission, n 0 (0–1) 0 (0–1) 0.939 0 (0–1) 0 (0–1) 0.545
exacerbations at home, n 2 (1–4.5) 2 (0–4) 0.085 2 (1.5–5) 2 (0–4) 0.214
subjective caring burden (FaCQ)
not enough time for myself 3 (2–4) 2 (2–3) 0.002* 3 (2.5–4) 2 (2–3) 0.003*
losing control over my own life 3 (2–4) 2 (1–2) ,0.0005* 3 (2.5–4) 2 (1–2) ,0.0005*
Feel tired and run-down 3 (2–4) 2 (1–3) ,0.0005* 4 (2.5–5) 2 (1.5–3) ,0.0005*
Isolated and alone 3 (2–4) 2 (1–2) 0.002* 3 (2–4) 2 (1–3) 0.001*
guilty about not being able to do more 4 (2–4) 2 (2–3) 0.001* 4 (3–5) 2 (2–4) ,0.0005*
My own health has suffered 3 (2–4) 2 (1–2) ,0.0005* 3 (3–4.5) 2 (1–2) ,0.0005*
had to give up social life 2 (2–3) 2 (1–2) 0.028* 3 (2–4) 2 (1–3) 0.001*
not been able to work or study as well 2 (2–4) 2 (1–2) 0.004* 3 (2–4.5) 2 (1–2) ,0.0005*
Financial difficulties 2 (2–3) 2 (1–3) 0.013* 3 (2–4) 2 (1–3) ,0.0005*
Unmet support needs (CsnaT)
CsnaT domains, n 4 (2–8) 2 (0–3) ,0.0005* 4.5 (2.3–8.8) 2 (0–4) 0.001*
Patient self-management
CrQ mastery 4 (1.3) 4.5 (1.3) 0.047* 4.1 (1.5) 4.4 (1.3) 0.31
Carer comorbidities
Physical comorbidities,a n 1 (1–2) 1 (0–2) 0.08 2 (1–3) 1 (0–2) 0.005*
anxiety symptoms, n (%) na na na 23 (88.5) 29 (33.3) ,0.0005*
Depression symptoms, n (%) 23 (44.2) 3 (4.9) ,0.0005* na na na
Notes: aany of allergies, arthritis, asthma, back pain, cancer, diabetes, epilepsy, cardiac disease, hypertension, renal disease, hepatic disease, or stroke. all values medians 
(IQr) unless otherwise stated. *P#0.05.
Abbreviations: FeV1, forced expiratory volume in 1 second; mMRC, modified Medical Research Council; FACQ, Family Appraisal of Caregiving Questionnaire; CSNAT, 
Carer support needs assessment Tool; CrQ, Chronic respiratory Questionnaire; na, not applicable.
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neuroanatomical regions.1,12 Interestingly, anxiety was only 
associated with exacerbations at home (not requiring hospital 
admission), which may support the hypothesis of overinter-
pretation of dyspnea9 or reflect higher anxiety from managing 
exacerbations in a nonclinical environment. There is evidence 
that systemic inflammation in exacerbations, with elevated 
interleukin-6 and C-reactive protein, leads to depressive 
symptoms.33 Inversely, anxiety and depression can increase the 
risk of exacerbations, through hypothalamic–pituitary–adrenal 
axis activation suppressing immune function.9 Anxiety and 
depression were also associated with fatigue and more physical 
comorbidities, which may be because these lead to physical 
inactivity, social isolation, and thus depression. Psychological 
morbidities may impair the ability to acquire skills and lower 
confidence in self-management, leading to poor mastery.3,9 
Finally, greater subjective symptom burden (CRQ scores) 
were significantly associated with anxiety and depression, but 
objective disease severity (% predicted FEV
1
) was not.
Being female was strongly associated with carer anxiety, 
in concordance with previous studies.13,15,17,18 Women may use 
more emotion-based coping strategies, or view the caregiving 
role negatively as a continuation of their sex role.13,17 The 
number of unmet carer-support needs had a robust association 
with carer anxiety and depression; the link between anxiety 
and carers being separated/divorced/widowed may also be 
related to lack of social support for the carer. Carers with 
depression were younger and of higher educational level, 
which (as with patients) may be due to difficulty adjusting 
to forced changes in lifestyle with the caring role, which 
would be greater for carers having their own physical comor-
bidities. Finally, anxiety and depression were significantly 
associated with greater subjective caring burden and anxiety 
with poor mastery by the patient (which could increase carer 
burden).
Importantly, we found that dyad anxiety or depression 
was significantly associated with greater patient fatigue. This 
may be explained by fatigue diminishing patient capacity to 
perform activities of daily living, thus increasing carer burden 
and reducing patients’ sense of independence, leading to 
psychological morbidity in both. Conversely, psychological 
morbidity in either patient or carer may impact on capacity 
for patient activity, resulting in deconditioning and fatigue.
Within Rolland’s family-system illness model, the asso-
ciations found between younger age and both patient and 
carer depressive symptoms may reflect the conflict between 
this chronic disease having a centripetal effect on the family 
(greater focus on internal family life) and a younger patient 
or carer being part of a family in a centrifugal period (which 
is when individual family members are more engaged in the 
extrafamilial environment). Living with advanced COPD 
as a patient or carer may necessitate sacrifices in personal 
autonomy, which can have profound permanent effects on 
the family life cycle. Additionally, advanced COPD usually 
occurs in late adulthood, when having or caring for illness 
is more expected: younger patients and carers may be in a 
life-structure-building/maintenance period and may be forced 
back into an “out of phase” transition period that is disrup-
tive. This is especially the case for diseases with a relapsing 
course, where the constant state of readiness required 
maintains the family in an out-of-phase state. Carers who 
were separated, divorced, or widowed were more likely to 
have symptoms of anxiety. This may be because separation 
represents a life-structure-changing period. When illness is 
concurrent with this, it can have a long-lasting impact on 
preparation for the next period of the life cycle. Finally, the 
link between patient mastery and patient and carer symptoms 
of anxiety and depression may be explained by mastery 
of illness being a key belief in the family’s belief system, 
which may influence the family’s account of illness and their 
strategies to adapt.
Clinical implications
As disease severity itself is not a barrier to psychological 
health, it is important to identify and address anxiety and 
depression in patients with advanced COPD. This study 
shows that it is feasible to use a simple tool, such as the 
Figure 1 Dyad symptoms of anxiety or depression associated with patient fatigue.
Notes: no aD (n=29), patient only aD (n=28), carer only aD (n=15), dyad aD 
(n=37). Data analyzed with one-way analysis of variance with Bonferroni post hoc 
test. error bars represent 95% CIs.
Abbreviations: aD, anxiety/depression; CrQ, Chronic respiratory Ques-
tionnaire.
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HADS, to screen for anxious and depressive symptoms in 
a clinical setting, which can indicate those who need more 
detailed assessment. Primary-care health professionals would 
be best placed to undertake this, to ensure coverage of the 
whole population of people living with advanced COPD. 
Clinicians should encourage all patients to participate in 
pulmonary rehabilitation, especially the exercise-training 
component, as this may represent the most effective way 
to interfere with the anxiety–dyspnea cycle.34 Education 
for patients and carers on managing breathlessness35 and 
exacerbations may reduce the anxiety associated with exac-
erbations at home. Pulmonary rehabilitation could also be an 
opportunity to increase physical activity and social interac-
tions, which may help to prevent depression. It is important 
that although patients have advanced COPD, clinicians 
appropriately manage (and do not neglect) comorbid physical 
conditions and do not attribute all symptoms to COPD.
Given their high prevalence and associations, it may be 
appropriate to screen carers (particularly of COPD patients 
with anxiety and depression) for anxiety and depression. 
Particular attention must be given to carers who are female, 
younger, separated, divorced, or widowed, who have physical 
medical conditions themselves, who report a higher caring 
burden or more unmet support needs, and who have patients 
who struggle to manage their own COPD. Possible interven-
tions include enabling carers to participate in care planning 
to improve understanding of COPD, education for carers 
on symptom control, and inclusion of carers in pulmonary 
rehabilitation programs, to reduce unmet support needs of 
the carer.35,36 Patients and carers may need access to respite 
care, and carers need time to attend to their own health 
(including their own medical conditions), work, and social 
life. Given the link between patient mastery and carer anxiety 
and depression, supporting patients in self-management of 
COPD could reduce psychological morbidity in carers.
Regarding the relationship between dyad anxiety and 
depression and patient fatigue, patients and carers could 
be supported to optimize their delegated dyadic coping: 
carers could offer balanced social support (so that they 
do not become overwhelmed themselves) and encourage 
patients to do as many everyday activities as they are able 
to before becoming too fatigued (to maintain a degree of 
self-efficacy).37
strengths and limitations
Important strengths of this study were the prospective design 
and recruitment of a population-based cohort sampled from 
primary care (which is most representative of the whole 
population of patients living with advanced COPD). Patients 
typically receive shared care, with the majority of care being 
undertaken in primary care and the involvement of secondary 
care signifying either severe exacerbations or progressive 
symptoms (a distinct experience), which some with COPD 
do not experience. The patients in our cohort were well char-
acterized in terms of their advanced COPD and sex-balanced. 
Research in COPD has historically focused on males, but 
females are increasingly affected by the condition, so are an 
important study group.
However the cross-sectional approach limited analyses to 
associations: longitudinal studies and analyses are needed to 
clarify the direction of causality and investigate changes in 
determinants of psychological health over time. The HADS 
is a self-report screening tool for symptoms of anxiety and 
depression, and not a formal physician diagnosis of anxiety 
or depression. Further, it asks about somatic symptoms that 
may equally be attributed to COPD. In addition, we did not 
control for any treatments for anxiety and depression that 
may have been received. Interviews with patients and carers 
were occasionally conducted together, where the physical 
layout of the home made separate interviews impossible. 
Previous studies have shown that combined and separate 
clinics with patients and carers in end-of-life care yield 
distinct findings. It has been shown that clinically, patients 
and carers value the time alone to voice their feelings and 
concerns, with patients expressing more cues that reveal 
emotion (surpassing the desire for information) and carers 
contributing more to conversation in private clinics.38 There-
fore, in joint interviews, it is possible patients and carers may 
have been more reluctant to express feelings of anxiety or 
depression. Nevertheless, the large majority of interviews 
were conducted separately, so we do not expect this to have 
significantly affected our results, but any effect would be 
an under- (rather than an over-) reporting of psychological 
morbidity in this population.
Conclusion
Symptoms of anxiety and depression of patients with 
advanced COPD and carers are significantly associated, and 
associated with younger age, female sex, being separated/
divorced/widowed, higher educational level, poor physical 
health, greater disease and subjective caring burden, unmet 
carer-support needs, and poor patient self-efficacy. Dyad 
symptoms of anxiety or depression were associated with 
greater patient fatigue. Given their high prevalence, consider-
able impact on mortality, quality of life, health care service 
use, and their associations with each other, it is necessary 
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to screen for and address anxiety and depression in patients 
and carers.
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